BTK and acute respiratory distress syndrome: The use of non-targeted siRNA against the background of ARDS induction in studies of BTK (Krupa et al.), NOX4, and CCL2 demonstrates that the therapeutic effect is not a consequence of non-specific interference of the siRNA itself or the carrier in the pathological process [97].